Your browser doesn't support javascript.
loading
Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis.
Fleischer, Vinzenz; Ciolac, Dumitru; Gonzalez-Escamilla, Gabriel; Grothe, Matthias; Strauss, Sebastian; Molina Galindo, Lara S; Radetz, Angela; Salmen, Anke; Lukas, Carsten; Klotz, Luisa; Meuth, Sven G; Bayas, Antonios; Paul, Friedemann; Hartung, Hans-Peter; Heesen, Christoph; Stangel, Martin; Wildemann, Brigitte; Then Bergh, Florian; Tackenberg, Björn; Kümpfel, Tania; Zettl, Uwe K; Knop, Matthias; Tumani, Hayrettin; Wiendl, Heinz; Gold, Ralf; Bittner, Stefan; Zipp, Frauke; Groppa, Sergiu; Muthuraman, Muthuraman.
Afiliação
  • Fleischer V; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Ciolac D; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Gonzalez-Escamilla G; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Grothe M; Department of Neurology, University Medicine of Greifswald, Greifswald, Germany.
  • Strauss S; Department of Neurology, University Medicine of Greifswald, Greifswald, Germany.
  • Molina Galindo LS; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Radetz A; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Salmen A; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Lukas C; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
  • Klotz L; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Meuth SG; Department of Neurology, University Hospital Münster, Westfälische-Wilhelms-University Münster, Münster, Germany.
  • Bayas A; Department of Neurology, University Hospital Münster, Westfälische-Wilhelms-University Münster, Münster, Germany.
  • Paul F; Department of Neurology, University of Duesseldorf, Duesseldorf, Germany.
  • Hartung HP; Department of Neurology, University Hospital Augsburg, Augsburg, Germany.
  • Heesen C; NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Charité, Universitätsmedizin Berlin and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Stangel M; Department of Neurology, University of Duesseldorf, Duesseldorf, Germany.
  • Wildemann B; Institute for Neuroimmunology and Multiple Sclerosis, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Then Bergh F; Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Tackenberg B; Department of Neurology, University of Heidelberg, Heidelberg, Germany.
  • Kümpfel T; Department of Neurology, University of Leipzig, Leipzig, Germany.
  • Zettl UK; Department of Neurology, Philipps-University Marburg, Marburg, Germany.
  • Knop M; F. Hoffmann-La Roche AG, Basel, Switzerland.
  • Tumani H; Institute of Clinical Neuroimmunology, Ludwig Maximilian University of Munich, Munich, Germany.
  • Wiendl H; Department of Neurology, Neuroimmunological Section, University of Rostock, Rostock, Germany.
  • Gold R; Max Planck Institute of Psychiatry, Munich, Germany.
  • Bittner S; Department of Neurology, University of Ulm, Ulm, Germany.
  • Zipp F; Department of Neurology, University Hospital Münster, Westfälische-Wilhelms-University Münster, Münster, Germany.
  • Groppa S; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Muthuraman M; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Ann Neurol ; 91(2): 192-202, 2022 02.
Article em En | MEDLINE | ID: mdl-34967456
ABSTRACT

OBJECTIVE:

Fatigue is a frequent and severe symptom in multiple sclerosis (MS), but its pathophysiological origin remains incompletely understood. We aimed to examine the predictive value of subcortical gray matter volumes for fatigue severity at disease onset and after 4 years by applying structural equation modeling (SEM).

METHODS:

This multicenter cohort study included 601 treatment-naive patients with MS after the first demyelinating event. All patients underwent a standardized 3T magnetic resonance imaging (MRI) protocol. A subgroup of 230 patients with available clinical follow-up data after 4 years was also analyzed. Associations of subcortical volumes (included into SEM) with MS-related fatigue were studied regarding their predictive value. In addition, subcortical regions that have a central role in the brain network (hubs) were determined through structural covariance network (SCN) analysis.

RESULTS:

Predictive causal modeling identified volumes of the caudate (s [standardized path coefficient] = 0.763, p = 0.003 [left]; s = 0.755, p = 0.006 [right]), putamen (s = 0.614, p = 0.002 [left]; s = 0.606, p = 0.003 [right]) and pallidum (s = 0.606, p = 0.012 [left]; s = 0.606, p = 0.012 [right]) as prognostic factors for fatigue severity in the cross-sectional cohort. Moreover, the volume of the pons was additionally predictive for fatigue severity in the longitudinal cohort (s = 0.605, p = 0.013). In the SCN analysis, network hubs in patients with fatigue worsening were detected in the putamen (p = 0.008 [left]; p = 0.007 [right]) and pons (p = 0.0001).

INTERPRETATION:

We unveiled predictive associations of specific subcortical gray matter volumes with fatigue in an early and initially untreated MS cohort. The colocalization of these subcortical structures with network hubs suggests an early role of these brain regions in terms of fatigue evolution. ANN NEUROL 2022;91192-202.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Fadiga / Esclerose Múltipla Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Fadiga / Esclerose Múltipla Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha